LEADING ARTICLE

Treatment of colorectal metastases: surgery, cryotherapy, or radiofrequency ablation

J N Primrose

Correspondence to:
Correspondence to:
J N Primrose, University Surgical Unit, F Level, Centre Block, Southampton General Hospital, Tremona Road, Southampton SO16 6YD, UK;
j.n.primrose{at}soton.ac.uk

The liver is the most common site of metastases from colorectal cancer. There has therefore been growing interest in how liver metastases may be ablated. The most common techniques for ablation of liver metastases are surgical resection, cryotherapy, and increasingly in recent years, radiofrequency ablation.

Keywords: colorectal cancer; liver metastases; cryotherapy; radiofrequence ablation

Abbreviations: 5-FU; 5-fluorouracil

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Johnson, E. E., Yamane, B. H., Buhtoiarov, I. N., Lum, H. D., Rakhmilevich, A. L., Mahvi, D. M., Gillies, S. D., Sondel, P. M. (2009). Radiofrequency Ablation Combined with KS-IL2 Immunocytokine (EMD 273066) Results in an Enhanced Antitumor Effect against Murine Colon Adenocarcinoma. Clin. Cancer Res. 15: 4875-4884 [Abstract] [Full Text]  
• Powell, L., Hood, G., Wyman, A. (2009). Gastrectomy for adenocarcinoma. Contin Educ Anaesth Crit Care Pain 9: 65-69 [Full Text]  
• Zytoon, A. A., Ishii, H., Murakami, K., El-Kholy, M. R., Furuse, J., El-Dorry, A., El-Malah, A. (2007). Recurrence-free Survival after Radiofrequency Ablation of Hepatocellular Carcinoma. A Registry Report of the Impact of Risk Factors on Outcome. Jpn J Clin Oncol 37: 658-672 [Abstract] [Full Text]  
• Chok, K. S., Ng, K. K., Poon, R. T. P., Lam, C. M., Yuen, J., Tso, W. K., Fan, S. T. (2006). Comparable Survival in Patients With Unresectable Hepatocellular Carcinoma Treated by Radiofrequency Ablation or Transarterial Chemoembolization. Arch Surg 141: 1231-1236 [Abstract] [Full Text]  
• Hombach, A, Schlimper, C, Sievers, E, Frank, S, Schild, H H, Sauerbruch, T, Schmidt-Wolf, I G H, Abken, H (2006). A recombinant anti-carcinoembryonic antigen immunoreceptor with combined CD3{zeta}-CD28 signalling targets T cells from colorectal cancer patients against their tumour cells. Gut 55: 1156-1164 [Abstract] [Full Text]